Bonyf N.V.
MLBON | BR
Overview
Corporate Details
- ISIN(s):
- BE6333353298
- LEI:
- 699400NGN0HE0QBIF505
- Country:
- Belgium
- Address:
- Doornzelestraat 114 bus D, 9000 Gent
- Website:
- https://bonyf.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
bonyf NV is a Belgian company specialising in the research, development, production and distribution of innovative oral and dental products. Its extensive range of patented products are the result of 20 years in-house research and development conducted in bonyf’s facilities in Liechtenstein. bonyf embodies Swiss premium quality and products are manufactured at bonyf’s production site in Switzerland under strict international regulations to ensure consistent quality.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-15 | Bogaert Jean-Pierre | Executive member | Sell | 4,900 | 82,810.00 EUR |
| 2025-05-01 | Bogaert Jean-Pierre | Executive member | Sell | 3,782 | 66,563.20 EUR |
| 2025-03-06 | Bogaert Jean-Pierre | Executive member | Sell | 15,000 | 262,500.00 EUR |
| 2025-02-26 | Bogaert Jean-Pierre | Executive member | Sell | 3,128 | 59,432.00 EUR |
| 2025-02-21 | Bogaert Jean-Pierre | Executive member | Sell | 1,986 | 36,741.00 EUR |
| 2025-02-13 | Bogaert Jean-Pierre | Executive member | Sell | 6,030 | 108,540.00 EUR |
| 2025-02-12 | Bogaert Jean-Pierre | Executive member | Sell | 1,300 | 24,700.00 EUR |
| 2024-12-30 | Bogaert Jean-Pierre | Executive member | Sell | 1,400 | 25,200.00 EUR |
| 2024-12-20 | Bogaert Jean-Pierre | Executive member | Sell | 1,250 | 23,750.00 EUR |
| 2024-12-17 | Bogaert Jean-Pierre | Executive member | Sell | 1,700 | 32,300.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |